| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.947 | 6.134 | 6.978 | 7.884 | 8.347 | 6.866 | 8.666 | 8.760 | 10.244 | 12.910 |
| Total Income - EUR | 5.947 | 6.134 | 6.978 | 7.884 | 8.347 | 7.439 | 8.666 | 8.760 | 10.244 | 12.910 |
| Total Expenses - EUR | 6.126 | 6.251 | 7.030 | 7.954 | 8.316 | 7.971 | 8.885 | 9.270 | 10.406 | 11.565 |
| Gross Profit/Loss - EUR | -179 | -118 | -52 | -70 | 31 | -532 | -219 | -510 | -162 | 1.345 |
| Net Profit/Loss - EUR | -357 | -240 | -122 | -147 | -52 | -597 | -305 | -598 | -265 | 958 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ascendent Terapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 86 | 381 | 323 | 472 | 478 | 816 | 531 | 523 | 600 | 1.884 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 13 | 12 | 12 | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 73 | 368 | 311 | 460 | 478 | 816 | 531 | 523 | 600 | 1.884 |
| Shareholders Funds | -1.989 | -2.209 | -2.294 | -2.399 | -2.404 | -2.956 | -3.196 | -3.803 | -4.057 | -3.076 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.293 | 2.806 | 2.845 | 2.871 | 2.883 | 3.772 | 3.727 | 4.326 | 4.657 | 4.960 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ascendent Terapy Srl